Hernan E. Gonzalez
Santiago, RM, Chile
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Intermediate-Risk Papillary Thyroid Cancer: Not Everyone Needs Radioactive Iodine.
Journal: Clinical endocrinology
Published: March 30, 2026
ThyroidPrint: Thyroid Genetic Classifier Long-Term Follow-Up of Benign Called Lesions.
Journal: Clinical endocrinology
Published: December 17, 2025
Two Decades of Thyroid Nodule Cytology in Children: Malignancy Risk Assessment at a Tertiary Care Center.
Journal: Hormone research in paediatrics
Published: May 31, 2024
Active surveillance is a feasible and safe strategy in selected patients with papillary thyroid cancer and suspicious cervical lymph nodes detected after thyroidectomy.
Journal: Archives of endocrinology and metabolism
Published: May 06, 2024
Lobectomy in patients with differentiated thyroid cancer: experience of a Chilean tertiary center.
Journal: Endocrine
Published: March 28, 2024
ThyroidPrint®: clinical utility for indeterminate thyroid cytology.
Journal: Endocrine-related cancer
Published: December 25, 2022
Warthin-like and classic papillary thyroid cancer have similar clinical presentation and prognosis.
Journal: Archives of endocrinology and metabolism
Published: May 25, 2021
A Thyroid Genetic Classifier Correctly Predicts Benign Nodules with Indeterminate Cytology: Two Independent, Multicenter, Prospective Validation Trials.
Journal: Thyroid : official journal of the American Thyroid Association
Published: January 08, 2020
In properly selected patients with differentiated thyroid cancer, antithyroglobulin antibodies decline after thyroidectomy and their sole presence should not be an indication for radioiodine ablation.
Journal: Archives of endocrinology and metabolism
Published: November 25, 2018
Genetic testing for indeterminate thyroid cytology: review and meta-analysis.
Journal: Endocrine-related cancer
Published: December 06, 2017
Last Updated: 09/26/2026